Multimodal Imaging Market Size, Share, Growth Analysis, By Technology(PET/CT, PET/MR, SPECT/CT, OCT/FMT), By Application(Brain & Neurology, Cardiology, Oncology, Ophthalmology), By End Use(Hospitals, Diagnostic Imaging Centers, Research and Academic Institutes, and Other End Users), By Region - Industry Forecast 2024-2031

Global Multimodal Imaging Market size was valued at around USD 3.9 billion in 2022 and is expected to rise from USD 4.1 billion in 2023 to reach a value of USD 6.3 billion by 2031, at a CAGR of 5.6% over the forecast period (2024–2031).

The established medical equipment companies and emerging companies determine the competitive landscape of the multimodal imaging sector. Industry players, including GE Healthcare, Siemens Healthcare, Philips Healthcare, and Canon Medical Systems with the high-tech imaging solutions dominate a huge market share. The R&D spending in these firms is considerable to come up with innovations in imaging technology and to provide improved system integration. Strategic elements also include alliances, acquisitions, joint ventures with medical facilities, academic institutions, and IT firms to increase market share and promote innovation.  'GE Healthcare ', 'Koninklijke Philips N.V. ', 'Canon Medical Systems Corporation ', 'Siemens Healthineers ', 'Zeiss Group ', 'Bruker ', 'Mediso Ltd. ', 'Neusoft Corporation ', 'Infraredx, Inc. (part of Nipro Corporation) ', 'Topcon Corporation ', 'Shanghai United Imaging Healthcare Co., Ltd. ', 'Heidelberg Engineering ', 'Spectrum Dynamics Medical ', 'Minfound Medical Systems Co., Ltd. ', 'Kindsway Biotech ', 'Sofie Biosciences, Inc. ', 'Fujifilm Corporation.', 'In October 2022, Spectrum Dynamics announced its latest development in digital nuclear medicine imaging: the ability to image with solid-state detector technology in a wide-bore, 3600-CZT based SPECT/CT configuration to detect high energy isotopes. The new generation VERITON-CT 400 Series Digital SPECT/CT scanners offer the possibility of opening both imaging applications in the heart, brain, and whole body. ', 'In April 2022, Mediso Ltd. acquired Bartec Technologies Ltd., a UK-based business, which has specializing business in the sales, installation, and maintenance of nuclear medicine and molecular imaging equipment and accessories. The acquisition will strengthen the position of the company within the UK and Ireland markets. However, financial details are not disclosed. ', 'In July 2021, Topcon Corporation has announced the acquisition of VISIA Imaging S.r.l. It is an ophthalmic imaging company whose headquarters are found in the suburbs of Florence, Italy.'

The global health network is gradually shifting focus on preventive treatment by designing ways to achieve better results while reducing costs. More vigilance on early disease detection is gradually becoming important, mainly attributed to multimodal imaging that allows both functional and anatomical assessments. This often helps to further diagnose such issues like cancer, neurological conditions, and cardiovascular conditions in at-risk populations early. This is coupled with early diagnosis trend, besides the progress in medical studies. 

Diagnostics in the Remote Area and Telemedicine: Multimodal imaging is slowly being integrated into telemedicine and remote diagnostic platforms. The image data may now be safely transmitted to experts to analyze and diagnose from a remote location due to the growing utilization of digital healthcare technologies. Telemedicine allows for this possibility and avenue for faster consultations, greater accessibility to advanced imaging, and improved patient outcomes in disadvantaged regions. This imaging modality gains greater access to rural and isolated areas due to the telemedicine trend on the rise. 

North America accounted for the highest multimodal imaging market share in 2022 and is predicted to be one of the spearheading regions in the forecast period as well. The market for this region is witnessing growth due to the presence of many prominent companies, including Siemens, GE Healthcare, and Koninklijke Philips N.V., in the region, along with advancements in technologies used for manufacturing multimodal imaging devices. The market is anticipated to grow due to the increasing adoption of advanced multimodal imaging technologies and the presence of a well-established healthcare infrastructure. The demand for multimodal imaging equipment also increased in the region because of the high health awareness from the public and the healthcare professionals about the importance of early diagnosis using imaging technologies.